Transformation: Charter council calls for more black asset managers

South Africa has issues to address around transformation and economic empowerment for it to create a more normal and equal society. Therefore it is important to keep abreast on the latest news from different corners. In this article we gain insight on a measurement of transformation in the financial sector especially in the asset management [...]

2018-05-18T09:16:32+02:00September 6th, 2017|

PPC hopes for new merger proposal with AfriSam

Business is all about making decisions that propel the venture into the future. In this article, we have a read about the possible PPC merger deal with AfriSam. Cement maker PPC is hoping to have a new merger proposal from AfriSam by the beginning of September, with the latest termination of merger talks sending PPC’s [...]

2018-05-18T09:16:49+02:00August 25th, 2017|

Not even 15% of analysts at stockbrokers are black

Transformation of the highly concentrated stockbroking sector is proceeding at a snail’s pace, with black stockbrokers involved in less than 2% of the value traded on the Johannesburg Securities Exchange. With 80% of the brokerage on the exchange being handled by only 10 of the 55 members of the JSE, little of the cake remains [...]

2017-08-17T10:27:21+02:00July 27th, 2017|

Planning for the future needs robust stakeholder participation

The Institute of Retirement Funds Africa (IRFA) put forward four questions to industry role players for its Analysis — Social Security and South Africa’s Retirement Funding Sector to provide in-depth consideration on the likely impact of government’s proposed social security reforms on South Africa’s retirement funding sector and present readers with a range of opinion. [...]

2017-08-17T11:12:28+02:00July 7th, 2017|

Watchdog probes Aspen for cancer drug pricing

Africa’s biggest generic drug maker Aspen Pharmacare, already under investigation by European authorities over the price of its cancer drugs, is now under similar scrutiny from SA’s Competition Commission. On Tuesday, the commission announced it was investigating Aspen and multinational pharmaceutical manufacturers Roche and Pfizer for suspected excessive pricing of their cancer drugs. If the [...]

2017-08-17T11:11:13+02:00June 13th, 2017|
Go to Top